Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Developing Treatments for Inflammatory Diseases	2.85M	2.37M	2.38M	1.21M
Developing Treatments for Inflammatory Diseases Growth	20.42%	-0.42%	96.37%	-
Total	2.85M	2.37M	2.38M	1.21M
Total Growth	20.42%	-0.42%	96.37%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	2.85M	2.37M	2.38M	1.21M
United States Growth	20.42%	-0.42%	96.37%	-
Total	2.85M	2.37M	2.38M	1.21M
Total Growth	20.42%	-0.42%	96.37%	-

Source: S&P Global Market Intelligence.